Patrick A Brown

Trials

Studies that name Patrick A Brown as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:45 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT02101853 · Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

  National Cancer Institute (NCI) · active not recruiting · Recurrent B Acute Lymphoblastic Leukemia · principal investigator
• Ph1/Ph2
  NCT00469859 · Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

  Children's Oncology Group · completed · Leukemia · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 16 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Developing FLT3-Targeted Therapy for Pediatric Leukemia
  K23CA111728 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2006 to 2010 · $140,130 awarded in 2010
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Children's Oncology Group Chair's Grant
  U10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013
  Named on NCT02101853
• COG NCTN Network Group Operations Center
  U10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026
  Named on NCT02101853